Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative study

ConclusionsEthical challenges raised by MDA of antibiotics for childhood mortality —which span socio-cultural issues, the environment, and effects on future generations—require consideration beyond traditional clinical trial review. The appropriate role of MDA also requires attention to concerns over ethical double standards and power dynamics in global health that affect how we view antibiotic use in HICs versus LMICs. Our findings suggest the need to develop additional, comprehensive guidance on managing ethical challenges in MDA.Graphical Abstract

http://link.springer.com/10.1186/s40249-022-01023-6

Source: Infectious Diseases of Poverty - September 16, 2022 Category: Infectious Diseases Source Type: research